FDA Device recall Z-2169-2017
AIA-PACK TgAb CONTROL SET
- FDA Device
- Class III
- terminated
- Published 2017-06-07
On 2017-06-07 the FDA classified a Class III recall of AIA-PACK TgAb CONTROL SET by Tosoh Bioscience, citing the label contains two different methodologies. Quality Control values for non-FDA approved methodology (CL) are on the label in addition to the FDA approved methodology values (A….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2169-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-02-08 |
| Published | 2017-06-07 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Tosoh Bioscience |
| Distribution | AK, FL, GA, MA, NY, OH, OK, TX |
Product
AIA-PACK TgAb CONTROL SET
Reason
The label contains two different methodologies. Quality Control values for non-FDA approved methodology (CL) are on the label in addition to the FDA approved methodology values (AIA). Two sets of instructions were included on the label.
Identifiers
| code_info | TgAb: G644899 Expires June 2017; G844801 Expires August 2017 & GX44802 Expires 09/30/2017. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2169-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.